ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases

JCO Precis Oncol. 2023 Aug:7:e2300130. doi: 10.1200/PO.23.00130.

Authors

Marta Bini^{1

2}, Justine Gantzer³, Armelle Dufresne¹, Hélène Vanacker^{1

4}, Clémence Romeo¹, Tatiana Franceschi⁵, Isabelle Treilleux⁵, Daniel Pissaloux^{4

5}, Franck Tirode^{1

4}, Jean-Yves Blay^{1

4}, Isabelle Ray-Coquard^{1

4}, Mehdi Brahmi^{1

4}

Affiliations

¹ Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
² Department of Medical Oncology, Istituto Nazionale dei Tumori di Milano, Milano, Italy.
³ Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
⁴ Université Claude Bernard Lyon 1, INSERM, Cancer Research of Lyon, France.
⁵ Department of Biopathology, Centre Léon Bérard, Lyon, France.

PMID: 37561982
DOI: 10.1200/PO.23.00130

No abstract available

Publication types

Case Reports

MeSH terms

Biomarkers
Female
Humans
Sex Cord-Gonadal Stromal Tumors* / diagnosis
Sex Cord-Gonadal Stromal Tumors* / genetics
Sex Cord-Gonadal Stromal Tumors* / pathology
Uterine Neoplasms* / diagnosis
Uterine Neoplasms* / genetics
Uterine Neoplasms* / pathology

Substances

Biomarkers
ESR1 protein, human